force_id,pt_report,xgb_report,psu_occlusion,pt_psu_gt,gpt_0shot_response,human_assessment0,yesno_gt
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01098548].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, it is predicted that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The XGBoost model indicates a very low probability (0.01098548) of the occluded outcome occurring, which suggests that it is highly unlikely that the patient has experienced seizures. Furthermore, the patient's MRI report and surgical history show no significant indicators of neurological complications, such as stroke or transient ischemic attacks, which often correlate with a higher risk of seizures. Thus, given the patient's clinical profile and the model's prediction, it is reasonable to conclude that seizures are not a concern for this patient.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00078829].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data for the main patient, the predicted clinical outcome regarding the history of pacemaker placement is **no**. The patient has no reported history of significant cardiac events, such as sustained cardiac arrhythmias or a history of postoperative complications that would typically necessitate pacemaker placement. Furthermore, the XGBoost model's prediction of a very low probability (0.00078829) for the occluded outcome suggests that the likelihood of having undergone a pacemaker placement is minimal. Taken together, these findings indicate that the patient is unlikely to have a history of pacemaker placement.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03919285].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I predict that the occluded outcome regarding whether the patient has died is ""no."" The significant aspects of the patient's history indicate a lack of severe complications commonly associated with increased mortality risk in single-ventricle patients, such as seizures, thrombus formation, or gastrointestinal issues like protein-losing enteropathy. Furthermore, the XGBoost model predicts a very low probability (3.92%) for the outcome being ""yes,"" reinforcing the interpretation that the patient is likely alive. Additionally, the absence of any severe comorbid conditions or adverse events noted in the metrics shows a favorable situation regarding the patient's overall clinical status.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.06742494].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict the missing clinical outcome regarding the patient's history of ascites (> trace) is ""no."" The XGBoost model's predicted probability of the occluded outcome being ""yes"" is quite low at 0.067, indicating that there is a very minimal likelihood of ascites being present in this patient. Moreover, the patient's MRI report and surgical history do not suggest any complications typically associated with ascites, such as renal dysfunction or hepatocellular issues. The absence of other complications and the overall positive clinical history further support the conclusion that this patient likely does not have a significant history of ascites.",1,0
BCH-ALDNOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00292091].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, the predicted outcome for the question ""Did the patient receive a heart transplant?"" is **no**. The key reasons for this prediction include the very low probability (0.00292091) according to the XGBoost model, which indicates that the model predicts a high likelihood that the occluded outcome did not occur. Furthermore, the patient's clinical status appears stable, with no significant history of complications post-Fontan surgery that would typically lead to heart transplant consideration, such as severe arrhythmias, thrombi, or major organ dysfunction. Given these factors, it is reasonable to conclude that the patient has not undergone transplant surgery.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.2804787].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the available data, it is reasonable to predict that the patient does not have a history of ascites (> trace). The patient has no history of pleural effusions, significant liver fibrosis, or other related complications typically associated with ascites. Furthermore, the XGBoost model's predicted probability of the occluded outcome being 'yes' is only 0.2804787, which suggests a low likelihood of ascites. Given these considerations, it is most plausible that the answer to the occluded outcome is ""no.""",1,0
BCH-BEABEN-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02138278].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the given information, I would predict that the missing clinical outcome, ""Has the patient died?"" is **no**. The XGBoost model predicts a very low probability (approximately 0.021) for the outcome indicating death, suggesting that it is not likely. Additionally, the patient's history shows no significant complications such as stroke, cardiac arrest, or other severe issues that are often associated with higher mortality risk, aside from the presence of an intracardiac thrombus and atrial tachyarrhythmias. Given the patient's good current status, lack of critical medical interventions, and the high accuracy of the model, it aligns with the conclusion that the patient has not died.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00061804].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, I would predict that the patient did not receive a heart transplant (no). The model's predicted probability of the occluded outcome being 'yes' (indicating that the patient did receive a heart transplant) is very low at 0.00061804, suggesting that the likelihood of this event occurring is negligible. Additionally, the patient's medical history shows no signs of significant deterioration that would typically necessitate a heart transplant, such as sustained ventricular tachyarrhythmias or severe renal dysfunction. The current management with anticoagulation and diuretics, combined with the absence of worse complications, further indicates that the patient is managing well post-Fontan surgery, reducing the likelihood of having undergone a transplant.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.09811153].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, the prediction for the missing clinical outcome—whether the patient has a diagnosis of seizures requiring antiepileptic medications—is ""no."" The patient has a relatively stable clinical profile, with no history of strokes, transient ischemic attacks, or other neurological issues that would typically contribute to seizure disorders. Additionally, the XGBoost model's predicted probability of 0.098, which is well below the threshold for a positive diagnosis, suggests a low likelihood of seizures occurring. Given these factors and the model’s strong performance metrics, it is reasonable to conclude that the patient likely does not have a diagnosis of seizures requiring antiepileptic medications.",1,0
BCH-BEABEN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00101269].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the XGBoost model's predicted probability of 0.00101269 for the occluded outcome of a history of pacemaker placement, it is highly likely that this patient does not have a history of pacemaker placement (predicted outcome: no). The model performance metrics indicate a very high accuracy and precision, which adds credibility to its prediction.

Furthermore, the patient exhibits significant arrhythmias, including atrial tachyarrhythmias, which might necessitate careful management. However, the absence of sustained ventricular tachyarrhythmias, cardiac arrest history, and other critical factors typically associated with the need for a pacemaker suggests that the likelihood of having undergone pacemaker placement remains low. Therefore, it seems reasonable to conclude that the patient does not have a history of pacemaker placement.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0024228].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I predict that the missing clinical outcome, whether the patient has died, is ""no."" The patient exhibits no significant complications or histories that typically lead to mortality in single-ventricle patients post-Fontan, such as thrombus formation, arrhythmias, or complications like protein-losing enteropathy or plastic bronchitis. Additionally, the XGBoost model gives a very low predicted probability (0.0024) for the outcome of death, which is supported by its high accuracy and AUC-ROC value, indicating that it is highly reliable in predicting this particular clinical outcome. Therefore, it is reasonable to conclude that this patient is still alive.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00478739].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, I predict that the main patient did not receive a heart transplant. The XGBoost model's prediction probability for the occluded outcome (heart transplant) being 'yes' is quite low at 0.0048, suggesting a very high likelihood that the patient did not undergo this procedure. Additionally, the patient's clinical history shows no signs of severe complications or progression towards end-stage heart failure often necessitating a transplant; they have no history of significant arrhythmias, cardiac dysfunction, or other serious conditions that may typically lead to such an intervention. Therefore, considering both the statistical prediction and the patient's favorable clinical status, it is reasonable to conclude that they did not receive a heart transplant.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00754037].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the information provided, I would predict that the main patient does not have a history of ascites (> trace) (no). This prediction is supported by the XGBoost model's estimated probability of the occluded outcome being 'yes', which is only 0.00754037, indicating a very low likelihood that the patient has ascites. Furthermore, the absence of significant cardiac events, such as sustained arrhythmias or complications related to Fontan physiology (e.g., protein-losing enteropathy or pleural effusions), suggests good overall cardiac stability. Therefore, with the combination of the model's output and the patient's relatively uncomplicated clinical history, it is reasonable to conclude that ascites is unlikely in this case.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03521026].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the information provided and the XGBoost model's prediction probability of 0.03521026, it is reasonable to predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient's MRI report and surgical history reveal no significant neurological issues or history of stroke, transient ischemic attacks, or other conditions that could predispose them to seizures. Furthermore, the absence of serious cardiac events and stable medications suggests a lower likelihood of neurovascular complications, reinforcing the model's prediction. Thus, the data collectively supports the conclusion that the patient is unlikely to have this condition.",1,0
BCH-BYRSAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.97609097].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided information, the missing clinical outcome—whether the patient has a history of pacemaker placement—is predicted to be **yes**. The XGBoost model has estimated a very high probability (0.9761) for the occluded outcome, suggesting that it is highly likely that the patient does have a pacemaker history, even if not explicitly stated in the other data. Additionally, the presence of post-Fontan electrophysiologic study indicates the patient has a complex electrical management situation, which often necessitates pacing support. Thus, the patient's surgical history and clinical status strongly support this prediction.",1,1
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01061994].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data and the XGBoost model prediction, it is most reasonable to conclude that the patient does not have a history of ascites (> trace), as indicated by the model's predicted probability of 0.01061994. The patient's MRI report and surgical history show no indication of significant complications often associated with ascites, such as protein-losing enteropathy or liver dysfunction, both of which could contribute to fluid accumulation. Additionally, the absence of any cardiac complications, apart from arrhythmias, suggests that the cardiac function may be maintained enough to avoid fluid-related issues like ascites. Given these factors and the model's high accuracy, the conclusion is supported that ascites is unlikely to be a concern for this patient.",1,0
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03477965].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, the predicted clinical outcome for the patient regarding the diagnosis of seizures requiring antiepileptic medications is **no**. This conclusion is supported by several factors in the patient's history, including the absence of severe complications usually associated with poor neurological outcomes, such as strokes or transient ischemic attacks. Additionally, the XGBoost model predicts a very low probability (approximately 0.035) of the occluded outcome occurring, suggesting that the likelihood of seizures in this patient is minimal. Given their relatively stable clinical status and lack of significant complications in their MRI and surgical history, it is reasonable to predict that a diagnosis of seizures requiring medication is unlikely.",1,0
BCH-CASKEV-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01886172].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data for the main patient, it is likely that the missing clinical outcome, ""Has the patient died?"", is ""no."" The patient has a complex surgical history but no significant complications typically associated with high mortality rates, such as major thrombus events, heart transplant history, or significant organ dysfunction. Moreover, the XGBoost model predicts a low probability (0.01886172) for the occluded outcome, suggesting that mortality is unlikely in this case. The combination of a favorable MRI report, absence of critical complications, and the model's strong accuracy supports the prediction that the patient is alive.",1,0
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00294164].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, the patient is unlikely to have received a heart transplant, as indicated by the predicted probability of the occluded outcome being 'yes' at only 0.0029. This extremely low probability suggests that, according to the XGBoost model, the likelihood of this patient undergoing a transplant is negligible. 

Additionally, the patient's clinical history exhibits notable issues such as sinus node dysfunction and atrial tachyarrhythmias, which may complicate the patient’s overall management but do not directly indicate a pathway to transplantation. Given the high performance of the model along with these clinical trends, it is reasonable to predict that the patient did not receive a heart transplant.",1,0
BCH-CASKEV-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.9987472].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I predict that the patient **does have a history of pacemaker placement** (yes). The high probability output from the XGBoost model at 0.9987472 strongly suggests that the occluded outcome—history of pacemaker placement—occurs for this patient. Additionally, the presence of atrial tachyarrhythmias and sinus node dysfunction increases the likelihood of requiring a pacemaker for rhythm management in patients with single-ventricle physiology post-Fontan surgery. The combination of these arrhythmias, along with the patient's reliance on beta-blockers and anticoagulants, points towards a significant need for pacing support, as these factors often correlate with arrhythmic complications in this demographic.",1,1
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? yes
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00752878].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, the patient has a complicated medical history, including significant respiratory distress, pedal edema, arrhythmias, and a recent death presumably due to malignant arrhythmia or arrhythmia arrest. Additionally, the XGBoost model estimates a very low probability (0.0075) of the patient having received a heart transplant. The absence of documented history of heart transplant and the patient's deteriorating condition leading to death suggest that a transplant was unlikely. Therefore, it is reasonable to predict that the patient did not receive a heart transplant.",1,0
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.3674904].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,"[' Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure\r\nShe was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""\n Has the patient died? yes\n If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest\n']","Based on the provided data and the XGBoost model’s prediction of a 36.7% probability that the patient has died, it appears that the odds favor the patient being alive, but there remains a notable risk of mortality. The patient's history of significant complications—including a history of intracardiac thrombus and atrial tachyarrhythmias—could increase the likelihood of poor outcomes, but the absence of chronic conditions such as protein-losing enteropathy and lack of renal dysfunction are protective factors. Additionally, the patient has not required a heart transplant, which is often associated with higher mortality in this cohort. Overall, while the model suggests a non-negligible risk of mortality, the preponderance of the clinical data leans towards the conclusion that the patient has not died.",0,1
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.6338589].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? yes\n'],"Based on the provided clinical data, it appears that the main patient has a complex medical history, including significant arrhythmias, a history of stroke, and intracardiac thrombus. The presence of non-sustained ventricular tachyarrhythmias suggests potential electrical instability that can correlate with neurological complications, such as seizures. Furthermore, the XGBoost model's predicted probability of 0.634 for the occluded outcome indicates a reasonable likelihood that the patient may indeed have seizures, especially given her symptomatic respiratory distress and deteriorating clinical status prior to death. Therefore, it is plausible to predict that this patient likely has a diagnosis of seizures requiring antiepileptic medications (yes).",1,1
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.15205666].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the information provided, the patient's history of respiratory distress and pedal edema suggests potential fluid overload or issues with venous return, which are commonly associated with ascites in patients with heart failure. Additionally, the presence of significant cardiac arrhythmias and a previous history of thrombus could contribute to heart dysfunction, leading to a likelihood of ascites as a complication. The XGBoost model predicts a probability of 0.152, indicating a low likelihood that the patient has a history of ascites; however, taking into account the patient's symptoms like edema and their deteriorating clinical status, it is reasonable to predict that the patient might have experienced ascites. Therefore, I would predict that the patient likely has a history of ascites (yes).",0,0
BCH-CIPEMI-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: superior mesenteric vein thrombosis extending to the portal splenic confluence and mean portal vein seen on CT after car accident
 Please provide any known details regarding the death: Presumed EP arrest secondary to heart failure
She was found dead at home in her bed. She was seen the week prior in clinic, with stable but significant respiratory distress and pedal edema. ""We were slowly increasing her diuretic regime. She had a history of arrhythmias. Dr. Freed who had followed for years felt it was likely an arrhythmic event. She was NYHA class 2-3 when I saw her.""
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00105251].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I predict that the patient does not have a history of pacemaker placement (no). The patient's MRI report indicates significant respiratory distress, pedal edema, and a history of arrhythmias without evidence of sustained arrhythmias that would typically necessitate a pacemaker. Additionally, there is no mention of prior defibrillator use or the need for electrophysiologic studies, which often relate to the management of arrhythmias. Considering the XGBoost model’s low predicted probability (0.00105251) of the outcome being 'yes', it strongly supports that the patient has not undergone pacemaker placement.",1,0
BCH-COBJAM-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02666651].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the information provided, the prediction for the missing clinical outcome, ""Has the patient died?"" is **no**. The predicted probability of the occluded outcome being 'yes' is 0.0267, which indicates a very low likelihood of death occurring. Furthermore, the patient's MRI report and surgical history reveal no significant comorbidities or complications typically associated with increased mortality risk, such as heart transplant status, significant arrhythmias, or severe pulmonary complications, which further supports the conclusion of survival post-surgery. Therefore, combining both the model's prediction and the clinical data suggests that this patient has not died.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00946598].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I predict that the main patient does not have a history of ascites (> trace). The patient has no recorded history of renal dysfunction, pleural effusions (both chylous and non-chylous), or signs of significant liver dysfunction (as indicated by the lack of elevated fibrosis tests), which are all factors that could contribute to ascites formation. Additionally, the XGBoost model's predicted probability of the occluded outcome being 'yes' is very low (approximately 0.0095), strongly suggesting that the patient is unlikely to have experienced ascites. Thus, the combination of their clinical history, MRI findings, and the model's prediction supports this conclusion.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00105511].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, the prediction for whether the patient has a history of pacemaker placement is **no**. The model's predicted probability of the occluded outcome being 'yes' is extremely low (0.00105511), indicating that the likelihood of the patient having had a pacemaker placed is negligible. Moreover, the patient's MRI report and surgical history do not mention any arrhythmias or significant electrical conduction issues that would typically necessitate pacemaker placement, as evidenced by the lack of documented atrial or ventricular tachyarrhythmias and other related interventions in the history. Given these factors, it is reasonable to conclude that the patient does not have a history of pacemaker placement.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00757991].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, the predicted outcome for whether the patient received a heart transplant is ""no."" The XGBoost model's predicted probability for the occluded outcome being 'yes' is low (0.00757991), indicating a strong likelihood that the patient did not require a transplant. Additionally, the patient's history shows no significant complications typically associated with the need for transplantation, such as severe cardiac arrhythmias, renal dysfunction, or other major adverse events that may strongly warrant such an intervention. The absence of these risk factors, combined with the model's accuracy and the patient's stable clinical status, supports the conclusion that a heart transplant was not necessary.",1,0
BCH-COBJAM-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? yes
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.43401805].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the available data, it is reasonable to predict that the missing clinical outcome is ""no"" regarding the diagnosis of seizures requiring antiepileptic medications. The patient has a history of stroke, which could potentially predispose them to seizures; however, there is no documented history of seizures or the use of antiepileptic medications, indicating they are not currently treated for them. Additionally, the XGBoost model’s predicted probability of the occluded outcome being 'yes' is 0.434, implying a lower likelihood that the patient has seizures, especially given the overall high accuracy and ROS metrics. Thus, the absence of other neurological issues or treatment history supports the prediction that the patient does not have seizures requiring antiepileptic medications.",1,0
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.5943146].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided data, I predict that the patient has a history of ascites (yes). The patient's MRI findings indicate ongoing renal dysfunction, as evidenced by a GFR < 60, and there is a history of non-chylous pleural effusions. These factors often correlate with fluid overload, which can lead to ascites in patients post-Fontan surgery. Additionally, the XGBoost model predicts the probability of the occluded outcome being 'yes' at 0.5943146, which suggests a near-even likelihood of this complication, further supporting this prediction.",1,1
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.07526835].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (""no""). The XGBoost model predicts a low probability (0.07526835) for the occluded outcome, suggesting that the model strongly indicates non-occurrence. Additionally, the absence of any neurological complications in the patient's history (e.g., no strokes, transient ischemic attacks, or history of hemoptysis) supports this prediction. The patient's MRI report and surgical history, while indicative of some serious issues (like renal dysfunction and elevated liver fibrosis), do not show any direct evidence pointing towards seizure activity or requirements for anticonvulsants.",1,0
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.97162825].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the information provided, I predict that the missing clinical outcome, ""Does the patient have a history of pacemaker placement?"" is likely to be ""yes."" The patient's MRI report indicates a history of atrial tachyarrhythmias and the use of multiple cardiac medications, including beta-blockers and anticoagulants, which often suggests a significant arrhythmic burden that may necessitate cardiac device support such as a pacemaker. Furthermore, the estimated probability of the occluded outcome being 'yes' is quite high (0.9716), which indicates that the model strongly predicts the presence of a pacemaker placement in this patient. Given these factors, it is reasonable to conclude that this patient likely has a history of pacemaker placement.",1,1
BCH-COFRAC-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.19102933].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, I predict that the occluded outcome ""Has the patient died?"" is likely ""no."" The patient's medical history shows a significant presence of other complications, such as renal dysfunction and history of pleural effusions, but there is no indication of severe acute events (like cardiac arrest or significant thromboembolic events) that would directly suggest a high mortality risk. Additionally, the XGBoost model's predicted probability of 0.191 suggests a low likelihood of mortality, especially considering the model's strong performance metrics. Thus, integrating the patient's history and the model prediction, it appears more plausible that the patient is alive.",1,0
BCH-COFRAC-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01764377].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data and the prediction model's output, it is reasonable to conclude that the patient did not receive a heart transplant. The XGBoost model predicts a very low probability (0.0176) for the occluded outcome, indicating a strong likelihood that the patient has not experienced this outcome. Additionally, the absence of severe complications such as significant thrombus events, cardiac arrest, or severe arrhythmias supports the idea that the patient's clinical status is relatively stable, which may diminish the need for heart transplantation. Altogether, these factors lead to the conclusion that the patient likely did not receive a heart transplant.",1,0
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.9928019].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided data, it is reasonable to predict that the patient has a history of pacemaker placement (yes). The patient has a significant history of atrial tachyarrhythmias, sinus node dysfunction, and has undergone a post-Fontan electrophysiologic study, all indicative of an arrhythmogenic profile that often necessitates the use of a pacemaker. Furthermore, the high probability of the occluded outcome being 'yes' (0.9928) strongly supports this conclusion, especially given the model's excellent performance metrics, indicating that similar clinical presentations in the training cohort often resulted in pacemaker placement. Therefore, considering the representation of the patient's clinical features and the predictive model, it is highly likely that this patient has a history of pacemaker placement.",1,1
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.5020602].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided patient data, it is reasonable to predict that the patient does not have a history of ascites (> trace) (no). The patient has multiple factors that suggest an overall health burden, including a history of renal dysfunction and positive liver fibrosis tests, which can be associated with fluid retention and potential complications such as ascites. However, the absence of pleural effusions and no report of chylous effusions, along with the patient having a current NYHA class condition and responsiveness to diuretics, suggest that any fluid overload might be managed effectively, indicating that ascites might not be present. The estimated probability from the XGBoost model (0.5020602) is close to 0.5, indicating uncertainty, but leaning towards the absence of ascites in this context.",0,1
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00538816].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the data provided, the predicted clinical outcome for the main patient regarding whether they received a heart transplant is ""no."" This prediction is supported by the XGBoost model's estimated low probability (0.0054) for the patient having undergone a heart transplant, indicating a very low likelihood. Furthermore, the patient's significant history of complications, such as renal dysfunction, positive liver fibrosis tests, and cardiac arrhythmias, suggests a challenging clinical picture that often precludes eligibility for transplant. The absence of critical interventions related to heart transplant further reinforces the likelihood that the patient has not received one.",1,0
BCH-DACKEL-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.06291912].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, it is more likely that the patient does not have a diagnosis of seizures requiring antiepileptic medications. The XGBoost model predicts a very low probability (0.0629) for the occluded outcome being 'yes,' which suggests that seizures are uncommon in this patient's cohort. Additionally, the patient's medical history indicates a significant presence of cardiovascular issues such as sinus node dysfunction, atrial tachyarrhythmias, and a history of stroke, but it lacks a direct mention of seizures or use of antiepileptic medications. This further supports the inference that seizures are not a significant concern for this patient.",1,0
BCH-DACKEL-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? yes
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.24075049].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the information provided, the prediction for the occluded outcome of whether the patient has died is ""no."" This conclusion is supported by several factors in the patient's history: they have a history of stroke, renal dysfunction, and elevated liver fibrosis tests, but no significant acute events such as cardiac arrest or major thrombus, which are typically associated with higher mortality in single-ventricle patients. Additionally, the XGBoost model calculated a relatively low probability (0.2408) for the occluded outcome being 'yes,' suggesting that the likelihood of death is more aligned with 'no'. The presence of managed chronic conditions and previous medical interventions, such as pacemaker placement and antiarrhythmic treatments, further suggests a focus on maintaining the patient’s stability and health.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00710511].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, the patient has a low predicted probability (0.0071) of receiving a heart transplant, indicating that the model strongly suggests the patient did not receive a transplant ('no'). Additionally, the patient's MRI report suggests a history of atrial tachyarrhythmias, which potentially complicates the clinical status and may imply a non-surgical management approach rather than proceeding to transplant. The absence of significant complications such as protein-losing enteropathy or major thrombotic events, along with the treatment regimen that includes anti-platelet and anticoagulant medications, further supports the likelihood of the patient being managed conservatively, rather than opting for heart transplantation.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0010774].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the low predicted probability of the occluded outcome being 'yes' (0.0010774), it is reasonable to predict that the patient does *not* have a history of pacemaker placement. The patient exhibits a history of atrial tachyarrhythmias and is on a beta-blocker, which may indicate arrhythmia management; however, without a prior history of sustained arrhythmias or any indication of pacemaker intervention in the clinical history, the likelihood of a pacemaker placement appears to be low. Furthermore, the absence of relevant cardiac complications such as significant rates of ventricular tachyarrhythmias or a history of cardiac arrest suggests a stable rhythm management approach, supporting the conclusion that the patient likely does not have a history of pacemaker placement.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.1187084].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, the predicted missing clinical outcome regarding whether the patient has a history of ascites (> trace) is ""no."" The absence of significant clinical findings that typically contribute to the development of ascites, such as a history of protein-losing enteropathy, renal dysfunction, or elevated liver fibrosis, supports this conclusion. Additionally, the XGBoost model estimates a low predicted probability of the occluded outcome being 'yes' (0.1187084), suggesting a low likelihood of this patient developing ascites. Given the patient's stable status without signs of chronic complications that would typically lead to fluid retention or ascites, it is reasonable to conclude that ascites is not present in this case.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0552157].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the available information, the predicted missing clinical outcome regarding whether the patient has a diagnosis of seizures requiring antiepileptic medications is **no**. The model's predicted probability of the outcome being 'yes' is quite low (0.0552157), indicating a strong likelihood that the patient does not have seizure-related diagnosis. Furthermore, the patient has a history of cardiac issues, including atrial tachyarrhythmias, and other complications like thrombus, but there is no mention of seizures or the use of antiepileptic medications in the patient’s medical history. This further supports the prediction that the patient is unlikely to have seizures that would require such treatment.",1,0
BCH-FIECOU-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: thrombotic occlusion of fenestration 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01601037].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, it is reasonable to predict that the patient has not died (""no""). The XGBoost model estimates a very low probability (0.016) for the outcome of death, indicating that the model strongly leans towards the patient surviving. Additionally, the patient's clinical history shows no significant acute crises such as major strokes, cardiac arrests, or persistent arrhythmias that could suggest imminent mortality. Furthermore, the absence of severe complications such as renal dysfunction or protein-losing enteropathy further supports a relatively stable clinical status, making it likely that the patient has not succumbed to their condition.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.07208246].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, I predict that the main patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient has no reported history of neurological complications such as stroke, transient ischemic attacks, or other significant events that may contribute to seizure activity. Additionally, there are no indications in the MRI report or other clinical history that suggest a propensity for seizures. The estimated probability from the XGBoost model of 0.072 suggests a low likelihood of the outcome occurring, thereby supporting the conclusion that the patient is less likely to have seizures requiring treatment.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00099053].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, the predicted missing clinical outcome of whether the patient received a heart transplant is likely ""no."" The XGBoost model estimates a very low probability (0.00099) of the patient having received a transplant, indicating that the model strongly predicts a 'no' outcome. Additionally, the absence of significant complications (such as cardiac arrest, thrombus, or arrhythmias) in the patient's medical history supports a stable post-Fontan condition, making the need for a heart transplant less likely in this instance. The patient's current NYHA classification suggests they are stable, further implying a reduced likelihood of requiring a transplant.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00088999].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, the likely prediction for the missing clinical outcome—whether the patient has a history of pacemaker placement—would be ""no."" The XGBoost model predicts a very low probability (0.00088999) for the occurrence of adverse outcomes, indicating that, given this patient's clinical features, the likelihood of having required a pacemaker is negligible. Furthermore, the absence of any documented arrhythmias, including sustained or non-sustained ventricular tachyarrhythmias, atrial fibrillation, or sinus node dysfunction, supports the conclusion that the patient's heart rhythm appears stable, reducing the need for a pacemaker. Therefore, it can be inferred that the patient does not have a history of pacemaker placement.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00079606].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I predict that the missing clinical outcome ""Has the patient died?"" is **no**. The patient has no history of severe complications related to Fontan surgery, including no instances of stroke, thrombus, or significant respiratory or hepatic issues. Additionally, the XGBoost model's estimated probability of the occluded outcome being 'yes' is extremely low (0.00079606), which strongly suggests that the model anticipates a negative outcome in this case. This aligns with the encompassed clinical data indicating the patient’s stable status post-surgery.",1,0
BCH-GRIJAH-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00930508].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided patient data and the XGBoost model's predicted probability of the occluded outcome being 'yes' (0.0093), it is highly likely that this patient does NOT have a history of ascites. The patient's detailed medical history shows no complications commonly associated with ascites, such as liver dysfunction or significant fluid retention (no chylous or non-chylous pleural effusions noted, and liver fibrosis tests are normal). Given the high accuracy of the model (93%) and the low predicted probability, it suggests that the risk of this patient having a history of ascites is very low. Therefore, the prediction would be ""no"" for a history of ascites.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.1640789].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data and the predicted probability from the XGBoost model, the missing clinical outcome of whether the patient has a diagnosis of seizures requiring antiepileptic medications is likely ""no."" The patient has a history of stroke and other significant complications such as intracardiac thrombus and arrhythmias, which may be associated with neurological events but do not directly indicate seizures. Additionally, the predicted probability (0.164) suggests a low likelihood of the occluded outcome (seizures requiring antiepileptic medications) occurring, especially in light of the high overall accuracy of the model. Therefore, it is reasonable to conclude that the patient does not have a diagnosis of seizures requiring treatment.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.5239016].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided information for the main patient, I predict that the patient has a history of ascites (> trace): **yes**. This prediction is supported by the presence of other concerning clinical features, including a history of liver fibrosis and hepatocellular carcinoma, both of which are associated with complications like ascites. The patient's MRI findings, along with significant issues such as hemoptysis and arrhythmias, suggest a progression of disease that predisposes them to fluid retention and portal hypertension, commonly leading to ascites development. Furthermore, the XGBoost model's predicted probability of 0.524 suggests that there is just over a 50% chance of the occluded outcome being 'yes', indicating a significant likelihood of such a condition existing.",1,1
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03200265].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, the patient likely did not receive a heart transplant. The XGBoost model predicts a low probability (0.032) for the occluded outcome, suggesting that the model sees a minimal likelihood of heart transplantation. Furthermore, the patient's history indicates significant complications, including intracardiac thrombus, a history of stroke, and hepatocellular carcinoma, all of which suggest a challenging clinical picture that could complicate candidacy for transplantation. Given these factors, it appears the patient did not undergo the heart transplant procedure.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.13145462].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information and the predicted probability from the XGBoost model (0.13145462), it's reasonable to predict that the patient has not died (outcome: ""no""). The notable clinical history of intracardiac thrombus, atrial tachyarrhythmias, and the presence of liver issues (elevated fibrosis tests, hepatocellular carcinoma, and ascites) indicate significant health challenges, but the model's strong performance (with high accuracy and AUC-ROC) coupled with a low predicted probability of death suggests that the occluded outcome is likely negative. Furthermore, the patient is currently on multiple medications, including a diuretic and beta blocker, indicating ongoing management rather than an end-of-life care approach.",1,0
BCH-GUYCOR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? yes
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? yes
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: no
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00645357].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the XGBoost model's predicted probability of the occluded outcome, it is highly likely that the main patient does **not** have a history of pacemaker placement (predicted outcome: no). While the patient's history includes significant issues such as intracardiac thrombus, hepatocellular carcinoma, and atrial tachyarrhythmias, there is no specific mention of symptomatic bradycardia or sinus node dysfunction that would typically warrant pacemaker placement. Moreover, considering the model's performance metrics, particularly the high accuracy and AUC-ROC, it further validates the prediction that the patient likely does not require such intervention, resulting in an extremely low predicted probability of having a pacemaker (0.00645357).",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0933895].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the available information, the predicted outcome for ""Does the patient have a diagnosis of seizures requiring antiepileptic medications?"" is **no**. The XGBoost model indicates a low predicted probability (0.0933895) for the outcome being 'yes,' suggesting that seizures are unlikely to be a significant issue for this patient. Furthermore, the patient has no history of other neurological complications such as stroke or transient ischemic attacks, which could increase the risk of seizures. Together, this clinical presentation and the model's strong performance metrics support the prediction that the patient does not have seizures requiring antiepileptic medications.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0526533].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided patient data, I predict that the patient does not have a history of ascites (> trace). The XGBoost model predicts a low probability (0.0526533) of the occluded outcome being 'yes', indicating that the model suggests a strong likelihood that ascites did not occur in this patient. Also, the absence of multiple significant complications such as protein-losing enteropathy, pleural effusions, and renal dysfunction further supports this prediction, as these conditions often correlate with fluid retention issues like ascites. Overall, the combination of the model's prediction and the patient's favorable clinical history leads to a confident conclusion that ascites is unlikely.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00583627].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data, it is reasonable to predict that the patient did not receive a heart transplant. The very low probability (0.0058) derived from the XGBoost model indicates that the likelihood of the occluded outcome (heart transplant) occurring is minimal. Furthermore, the patient has a clean surgical history with no reports of severe complications such as cardiac arrests, thrombi, or significant arrhythmias, which often necessitate a transplant. The use of anticoagulants, ACE inhibitors, and diuretics suggests appropriate management of any underlying issues post-surgery, reinforcing that the patient is functionally stable without the need for transplantation at this time.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0152536].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I predict that the missing clinical outcome, ""Has the patient died?"" is **no**. The main patient has a number of favorable indicators: there is no record of serious complications post-surgery, such as thrombus formation, stroke, or cardiac arrests, and they are currently prescribed multiple medications that suggest ongoing management of their condition. Additionally, the XGBoost model indicates a very low predicted probability of 0.0152536 for a positive outcome (i.e., death), which indicates that the model strongly favors survival in this case. Given the patient's lack of significant adverse events and the strong predictive performance of the model, it is reasonable to conclude that the patient has not died.",1,0
BCH-HOHMIL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00113855].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the predicted probability from the XGBoost model, it is reasonable to conclude that the main patient does not have a history of pacemaker placement. The model estimates a very low probability (0.00113855) for the occluded outcome being 'yes', indicating that complications associated with the main patient, such as those requiring pacemaker intervention, are highly unlikely. Furthermore, the patient's surgical history and MRI findings show no significant indications that would typically lead to the need for pacemaker placement, such as atrial tachyarrhythmias or other electrophysiological abnormalities. Therefore, the prediction is that the patient does not have a history of pacemaker placement.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01033198].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, it is predicted that the patient does not have a diagnosis of seizures requiring antiepileptic medications. The patient's MRI report and surgical history reveal a low prevalence of complications and adverse conditions such as strokes or thrombi, which are often associated with seizures. Furthermore, the probabilistic prediction from the XGBoost model suggests a very low risk (0.01033198) for the occluded outcome, indicative of a very likely absence of seizures. Given the patient's overall clinical stability and specific negative histories reported, this further supports the conclusion that seizures requiring antiepileptic medication are unlikely in this case.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02826067].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict that the missing clinical outcome regarding whether the patient has a history of ascites (> trace) is **no**. The patient's MRI report and surgical history do not indicate any significant medical issues that are commonly associated with ascites, such as liver dysfunction or protein-losing enteropathy. Additionally, the XGBoost model predicts a low probability (0.0283) of the occurrence of the occluded outcome, further supporting the likelihood that ascites is not present in this patient. Overall, the combination of the patient's stable clinical profile and the model's assessment suggests that he does not have a history of ascites.",1,0
BCH-KATNAT-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01826304].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided patient data, the prediction for the missing clinical outcome, ""Has the patient died?"" is **no**. The XGBoost model estimated a very low probability of the occluded outcome being 'yes' (0.0182), which indicates that there is a strong likelihood the patient has not died. Additionally, the absence of significant cardiovascular complications, such as sustained ventricular tachyarrhythmias or a history of serious postoperative events, further supports the inference that the patient has likely maintained stability post-surgery. Overall, the combination of the model's prediction and the lack of critical adverse history points towards a negative outcome for the patient's mortality status.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00105299].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the available information regarding the patient, including the MRI findings and surgical history, it is reasonable to predict that the patient does not have a history of pacemaker placement (no). The patient has a history of arrhythmias, specifically atrial tachyarrhythmias and non-sustained ventricular tachyarrhythmias, which are often managed with medication and electrophysiologic studies rather than immediate device placement. The absence of significant sustained arrhythmias (e.g., sustained ventricular tachycardia) or requirements for a defibrillator suggests that the current arrhythmias may not warrant a pacemaker, in alignment with the low predicted probability from the XGBoost model indicating that complications that would typically lead to pacemaker placement are unlikely.",1,0
BCH-KATNAT-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00545165].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the available data, I predict that the missing clinical outcome, ""Did the patient receive a heart transplant?"" is ""no."" The XGBoost model's predicted probability of the occluded outcome is 0.00545165, indicating a very low likelihood of heart transplant compared to the absence of such an intervention. Additionally, the patient's clinical history suggests moderate arrhythmias but they have not experienced critical complications such as sustained ventricular tachyarrhythmias, stroke, or significant postoperative issues, which often lead to transplant consideration. Therefore, based on both the model output and the clinical context, it is reasonable to conclude that the patient did not receive a heart transplant.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.05793077].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the available data, it is reasonable to predict that the patient has not died (""no""). The XGBoost model's predicted probability for the occluded outcome, which is death in this context, is approximately 0.058, indicating a very low likelihood of this event occurring. Furthermore, the patient's MRI report and surgical history show no history of critical complications, such as cardiac arrest, thrombus, or significant arrhythmias that might contribute to increased mortality risk. Additionally, the patient's current medical management, which includes anticoagulants and multiple anti-hypertensive medications, suggests that the patient is stable and under careful observation, further supporting the prediction that the patient has not died.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01177647].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the patient's detailed clinical history and the predictions from the XGBoost model, it is reasonable to predict that the patient did **not** receive a heart transplant. The model's estimated probability of 0.0118 for receiving a transplant indicates a very low likelihood of this outcome occurring. Furthermore, the absence of significant complications typical for patients that might require transplant—such as sustained ventricular tachyarrhythmias or significant organ dysfunction—combined with the current management regime (including beta blockers and anticoagulants) point toward a stable clinical status. Additionally, the history of atrial arrhythmias may be managed without necessitating a transplant, aligning with the predicted outcome.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02474691].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, particularly the XGBoost model's prediction probability of 0.02474691 for the outcome of having a history of ascites, it strongly suggests that the occluded outcome is likely 'no.' This low probability indicates that, within the context of the model's training and validation on a similar cohort, the patient is unlikely to have experienced this complication. Additionally, the patient's clinical history shows no significant signs of hepatic dysfunction or complications commonly associated with ascites, such as elevated liver fibrosis, which further supports the conclusion that the patient does not have a history of ascites. Therefore, it is reasonable to predict that the patient does not have a history of ascites (> trace).",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02611402].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, the prediction for the occluded outcome, regarding whether the patient has a diagnosis of seizures requiring antiepileptic medications, is ""no."" This prediction is supported by the patient's stable critical medical history, which indicates no significant neurological events such as strokes or transient ischemic attacks that often precede seizure disorders. Additionally, the history reveals only arrhythmias without mention of seizures or the use of antiepileptic medications, and the XGBoost model's predicted probability of 0.02611402 strongly favors the absence of the outcome, suggesting a low likelihood of seizures in this patient cohort. Thus, the probability and the lack of related clinical events guide the conclusion towards the management of their existing conditions rather than seizures.",1,0
BCH-LEOJUL-1," Pt Status Event Update 
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: exaggerated sinus node behavior and was started on ivabradine
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? yes
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00112648].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the model's predicted probability, it is reasonable to predict that the patient does not have a history of pacemaker placement (no). The patient's MRI report and surgical history indicate concerns related to atrial tachyarrhythmias and the history of antiarrhythmic interventions, but there is no mention of significant bradyarrythmias or sinus node dysfunction that typically necessitate a pacemaker. Moreover, the XGBoost model's prediction probability of 0.00112648 strongly suggests that the occluded outcome is unlikely to be present, supporting the conclusion that the patient has not undergone pacemaker placement.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00734286].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided patient data and the XGBoost model's predicted probability of the occluded outcome being 'yes' at 0.0073, it is highly plausible that the outcome is 'no', indicating that the patient has not died. The model's strong performance metrics, with an accuracy of 0.96 and an AUC-ROC of 0.87, support this prediction. Furthermore, the absence of critical complications often associated with poor outcomes, such as intracardiac thrombus or significant cardiac events (e.g., stroke, cardiac arrest), suggests a relatively stable condition post-surgery. Therefore, given the low predicted probability and clinical data indicating no severe acute complications, the most reasonable prediction is that the patient has not died.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01843921].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, it is reasonable to predict that the missing clinical outcome regarding the history of ascites (> trace) is ""no."" The patient's MRI report and surgical history do not indicate any prior history of significant fluid retention issues, such as pleural effusions or protein-losing enteropathy, which could commonly correlate with ascites. Additionally, the predicted probability from the XGBoost model (0.01843921) suggests a very low likelihood of the patient experiencing this outcome, aligned with a generally healthy clinical status in the absence of any significant liver dysfunction or related complications noted in the history. Thus, it supports the conclusion that the patient likely does not have a history of ascites.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00085787].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the available data, the predicted outcome for whether the patient received a heart transplant is **no**. The XGBoost model's predicted probability of the occluded outcome being 'yes' is extremely low (0.00085787), which suggests the model does not support the likelihood of the patient having undergone a transplant. Additionally, the patient's MRI and post-surgical history indicate complications such as intracardiac thrombus and significant arrhythmias (atrial tachyarrhythmias and sinus node dysfunction), which typically complicate clinical decisions and could reduce transplant eligibility. Given these factors and the high accuracy of the model, it's reasonable to conclude that this patient did not receive a heart transplant.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.07493094].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information about the patient, the XGBoost model estimates a low probability (0.07493094) for the occluded outcome being 'yes', which suggests a strong likelihood that the patient does not have a diagnosis of seizures requiring antiepileptic medications. Additionally, the patient's MRI reports do not indicate any concerning neurological issues such as a history of stroke or transient ischemic attacks, which could be risk factors for seizures. Furthermore, the absence of any documented use of antiepileptic medications further supports the prediction that the patient likely does not have seizures. Therefore, the missing clinical outcome can reasonably be predicted as 'no'.",1,0
BCH-MANYOH-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: swelling and boils on right leg after percutaneous sclerotherapy procedure. Later He went to the OR with IR for an incision and drainage of the clot burden.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00215312].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, it is predicted that the patient does **not** have a history of pacemaker placement (""no""). The main patient has experience with atrial tachyarrhythmias and sinus node dysfunction, which could potentially lead to the need for pacing; however, there is no indication in their medical history that they have undergone pacemaker placement. Additionally, the XGBoost model's predicted probability of the occluded outcome being 'yes' is extremely low (0.00215312), suggesting that the likelihood of this patient having a history of pacemaker placement is minimal, given the model's high performance metrics. Therefore, it seems that the absence of such a record aligns with the low probability indicated by the model.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00801779].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data and the results from the XGBoost model, it is predicted that the patient did not receive a heart transplant (no). The predicted probability of the occluded outcome being 'yes' is extremely low at 0.00801779, suggesting a very high likelihood that the occluded outcome did not occur. Additionally, the patient's absence of significant complications or conditions often associated with the progression to heart transplant, such as worsening heart function or severe cardiac arrhythmias, further strengthens this prediction. With a current NYHA class status indicating manageable symptoms, along with a regimen of medications including ACE inhibitors, diuretics, and pulmonary vasodilators, it seems the patient has maintained stability post-Fontan surgery, reducing the necessity for transplantation.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.05004829].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, the prediction for the occluded clinical outcome regarding whether the patient has a history of ascites (> trace) is **no**. The main patient has a comprehensive absence of various complications commonly associated with single-ventricle patients who have undergone Fontan surgery, such as protein-losing enteropathy, renal dysfunction, and significant pleural effusions. Additionally, the XGBoost model generates a low probability (5.00%) that ascites is present, indicating that it's highly unlikely for this patient. Taken together, these factors suggest that the patient is not experiencing ascites, consistent with their overall stable clinical profile post-surgery.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00267014].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided patient information, the prediction for whether the patient has a history of pacemaker placement is **no**. The patient exhibits no significant cardiac arrhythmias, including sustained or non-sustained ventricular tachyarrhythmias, atrial fibrillation, or other indications typically warranting pacemaker intervention, which suggests a stable cardiac rhythm. Additionally, the lack of major adverse events, such as cardiac arrests or significant thrombus episodes, further supports the conclusion that pacemaker placement was not necessary. Coupled with the predicted probability of 0.00267014 from the XGBoost model, which strongly implies that the occluded outcome of a history of pacemaker placement did not occur, it reinforces the assertion that the answer is 'no'.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0661893].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, the predicted outcome for whether the patient has a diagnosis of seizures requiring antiepileptic medications is ""no."" The XGBoost model estimates a low probability (0.0661893) for the occurrence of the occluded outcome, suggesting a strong likelihood that seizures do not need to be treated with antiepileptic medications for this patient. Additionally, the patient exhibits none of the significant complications or symptoms typically associated with an increased risk of seizures, such as a history of stroke or significant cardiac issues. This aligns with the model's high accuracy and AUC-ROC, indicating that the clinical features do not support the presence of this diagnosis.",1,0
BCH-MOLFRA-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01406133].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, I would predict that the missing clinical outcome, ""Has the patient died?"", for the main patient is **no**. The patient's MRI report shows no significant complications or serious diagnoses that could lead to mortality, such as stroke, thrombus, renal dysfunction, or cardiac arrest. Furthermore, the XGBoost model's predicted probability of the occluded outcome being 'yes' is very low at 0.014, indicating the model suggests a high likelihood that the patient is alive. Combining these insights strongly suggests that the patient has not died.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00164473].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data and the predicted probability from the XGBoost model, it is reasonable to conclude that the patient did not receive a heart transplant (predicted outcome: no). The model's output indicates a very low probability (0.0016) of the occluded outcome occurring, suggesting the likelihood of heart transplant is minimal. Additionally, the patient's clinical history reveals no significant complications typically associated with heart transplant candidacy, such as sustained ventricular arrhythmias, severe heart failure, or organ dysfunction, which further supports the prediction that a heart transplant was not needed in this case.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.05693256].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient's MRI report indicates a history of atrial tachyarrhythmias and an emergent medical history but does not document any neurological issues or episodes indicative of seizures, such as transient ischemic attacks or strokes. Furthermore, the XGBoost model's predicted probability of the occluded outcome being 'yes' is quite low at approximately 0.057, suggesting that the likelihood of the patient having seizures is minimal. Considering the high accuracy of the model, this prediction further reinforces the conclusion that this patient likely does not have a diagnosis of seizures requiring treatment with antiepileptic medications.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0012332].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I predict that the patient does **not** have a history of pacemaker placement. The patient has a history of atrial tachyarrhythmias, which suggests cardiac arrhythmias that might require monitoring, but there is no indication of sustained ventricular arrhythmias or dysfunctions such as sinus node dysfunction, which would typically necessitate the placement of a pacemaker. Furthermore, the XGBoost model's estimated probability of the occluded outcome (history of pacemaker placement) being 'yes' is extremely low at 0.0012332, suggesting that it is highly unlikely that this patient has undergone pacemaker placement. Given the lack of other significant cardiac issues, the data collectively supports the notion that pacemaker intervention was not needed.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03090512].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided patient's data and the XGBoost model's prediction, it is reasonable to predict that the patient does not have a history of ascites (> trace) (no). The model estimated a very low probability (0.0309) for the occurrence of the occluded outcome, suggesting that the vast majority of similar patients did not experience this complication. Furthermore, the absence of significant clinical issues such as pleural effusions or liver-related complications further supports this prediction. The patient's overall clinical status, surgical history, and lack of any noted conditions typically associated with ascites reinforce this conclusion.",1,0
BCH-MORMAX-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: admitted to the CICU via transport from an outside hospital. He had a 2 day history of nausea and vomiting. His heart rate was noted to be increased by his mother and he presented to the local Emergency Room with a heart rate between 230 and 240 beats per minute. He was given adenosine x 2 and diltiazem x 1 without response and was transferred in a narrow complex tachycardia, atrial flutter to Boston Children's Hospital. 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00904842].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the information provided and the model's prediction, the missing clinical outcome of whether the patient has died can be predicted as **no**. The predicted probability of the occluded outcome being 'yes' is exceedingly low at 0.009, suggesting a very high likelihood that the patient is alive. Furthermore, the patient has a history of emergent cardioversion and atrial tachyarrhythmias but no significant adverse conditions like stroke, renal dysfunction, or major thrombus events that would typically indicate a poorer prognosis. Therefore, considering both the clinical data and the model's performance metrics, it is reasonable to conclude that this patient has not died.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00420892].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided clinical history and conditions of the main patient, I predict that the missing clinical outcome, *Has the patient died?*, is **no**. The patient's MRI report shows no critical complications, such as thrombus history, significant arrhythmias beyond atrial tachyarrhythmias, or any indication of major adverse events like stroke or cardiac arrest. Additionally, the XGBoost model's estimated probability of the occluded outcome being 'yes' is remarkably low at 0.0042, greatly supporting the notion that the patient has not died, especially since the model exhibits strong predictive performance with a high accuracy of 96%. This combination of clinical data and the model's output strongly indicates that the patient remains alive.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02400114].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided XGBoost model prediction, which estimates a very low probability (0.02400114) of the patient having a diagnosis of seizures requiring antiepileptic medications, it is reasonable to predict that the patient does not have this diagnosis. Additionally, the absence of other significant neurological events in the patient’s history, such as strokes or transient ischemic attacks, further supports this conclusion. Moreover, the patient's history of atrial tachyarrhythmias and the use of other medications suggest a complex cardiac condition rather than a primary neurological issue. Therefore, it is predicted that the patient does **not** have a diagnosis of seizures requiring antiepileptic medications.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00092633].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the XGBoost model's output, I predict that the main patient does not have a history of pacemaker placement (no). The patient's MRI report and surgical history do not indicate any significant arrhythmias that would commonly necessitate pacemaker placement. Although the patient has a history of atrial tachyarrhythmias and has undergone elective cardioversion, this does not inherently imply a need for permanent pacing, especially considering the high probability of a negative outcome for history of pacemaker placement predicted by the XGBoost model (0.00092633). The overall clinical stability indicated by the absence of serious complications further supports this prediction.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00159513].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, it is predicted that the patient did not receive a heart transplant (no). The model's predicted probability of the occluded outcome being 'yes' is extremely low at 0.0016, suggesting a very low likelihood of having undergone transplantation. Furthermore, the patient's surgical history shows ongoing management of arrhythmias, demonstrated by the history of atrial tachyarrhythmias and elective cardioversion, rather than indications of end-stage heart failure typically warranting a transplant. The absence of other significant complications or deteriorating health status further supports this conclusion, as patients in need of heart transplants often have more severe conditions like renal dysfunction or recurrent cardiovascular events.",1,0
BCH-MOSSTA-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.12282468].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, the predicted outcome for whether the patient has a history of ascites (> trace) is **no**. The XGBoost model estimates a low probability of occurrence (0.1228) for the occluded outcome, indicating that the model leans towards the patient not having a history of ascites. Additionally, the patient has no documented history of significant complications such as renal dysfunction or protein-losing enteropathy, both of which are often associated with fluid accumulation like ascites. The absence of these underlying conditions, along with the strong performance metrics of the predictive model, suggests that it's unlikely the patient has a history of ascites.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00370407].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data for the main patient, the predicted clinical outcome for whether the patient has a history of pacemaker placement is ""no."" The patient's MRI report shows no history of arrhythmias, cardiac arrest, or any significant electrical issues, which typically necessitate a pacemaker. Additionally, the XGBoost model predicts a very low probability (0.00370407) of any adverse outcomes that might warrant pacemaker placement, further supporting this prediction. Therefore, given the combination of clinical history and the model's strong performance, it is reasonable to conclude that the patient likely does not have a history of pacemaker placement.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.23069319].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided patient data and the XGBoost model prediction, I would predict that the patient does **not** have a history of ascites (> trace). The probability of having ascites, as estimated by the model, is relatively low (0.2307), suggesting a 23% chance that the patient has this condition, which is below the threshold commonly considered for a positive diagnosis. Furthermore, the absence of other complicating factors such as chylous effusions or significant liver dysfunction (as indicated by a positive Fibrosure test) further supports the likelihood that the patient does not have a significant history of ascites. Given these patterns and the strong performance metrics of the model, it is reasonable to conclude that the missing outcome should be ""no"".",0,1
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.06353018].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the patient's clinical history and MRI report, I predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The low probability (0.0635) output by the XGBoost model suggests that the likelihood of the occluded outcome being 'yes' is minimal. Additionally, the patient's history indicates no major neurological complications such as stroke or transient ischemic attacks, which might lead to seizures. The absence of conditions that commonly predispose to seizure activity further strengthens the prediction that the patient likely does not require antiepileptic medications.",1,0
BCH-NUSPIN-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.6036864].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, I predict that the patient did receive a heart transplant (yes). The presence of an intracardiac thrombus, significant liver issues indicated by a positive fibrosure and ascites, as well as being on anticoagulant therapy point toward severe complications post-Fontan surgery. Additionally, the XGBoost model's predicted probability of the occluded outcome being 'yes' is 0.6037, which is above the threshold of 0.5, suggesting that there is a considerable likelihood of transplant being necessary in this patient's case. Overall, the complex medical history and the model's prediction strongly suggest that a heart transplant was warranted.",0,0
BCH-NUSPIN-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? yes
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.6600426].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the information provided, I predict that the missing clinical outcome, ""Has the patient died?"", is likely ""no."" The patient has a history indicating the presence of an intracardiac thrombus, which contributes to risks, but there are no documented histories of significant complications such as stroke or cardiac arrest. Additionally, the XGBoost model predicts a probability of 0.66 for the outcome being ""yes,"" which is close to the threshold of uncertainty. However, given the overall context and the patient's ongoing treatment with anticoagulants, ACE-I/ARB, and diuretics without severe complications documented, it suggests a maintained clinical status, supporting the prediction of survival.",1,0
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03586051].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,"[' Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. \n Has the patient died? yes\n If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest\n']","Based on the provided clinical data for the patient, the predicted probability of death post-Fontan surgery is very low at approximately 0.036, indicating that the model strongly suggests a ""no"" for the outcome of death. The patient's history shows that they have experienced complications, including intracardiac thrombus and atrial fibrillation, but there are no recorded incidences of significant adverse events such as strokes or cardiac arrests. Furthermore, other indicators, such as absence of protein-losing enteropathy, renal dysfunction, and the high accuracy of the model, support the likelihood that this patient has not died. Therefore, it is reasonable to conclude that the occluded outcome, ""Has the patient died?"" is predicted to be ""no.""",0,1
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00107643].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, it is highly unlikely that the patient has a history of pacemaker placement. The patient exhibits a range of arrhythmic issues, including atrial fibrillation that required cardioversion, but there is no documented history of sustained ventricular tachyarrhythmias or the need for a defibrillator, which often suggests a more severe degree of arrhythmia that necessitates pacing support. Furthermore, the patient's reported events of embolism and thrombus are more closely associated with anticoagulation management than mechanical pacing, lending further credence to the prediction that a pacemaker was not needed by this patient. The XGBoost model's predicted probability of the occluded outcome (0.00107643) further supports the conclusion that a history of pacemaker placement is unlikely, suggesting the automatic response would be ""no.""",1,0
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.19984475].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided information about the main patient, I predict that the occluded clinical outcome, ""Does the patient have a history of ascites (> trace)?"", is likely **no**. The patient exhibits several significant risk factors like a history of hemoptysis and atrial fibrillation, which are associated with poorer outcomes post-Fontan, but no documented history of ascites is mentioned in the report. Additionally, the XGBoost model predicts a probability of only approximately 0.20 for the presence of this outcome, indicating that it is relatively unlikely. Thus, considering both the patient's clinical data and the predictive model's output, it supports the conclusion that the patient does not have a history of ascites.",0,1
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.06891212].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the available data, I would predict that the missing clinical outcome—whether the patient has a diagnosis of seizures requiring antiepileptic medications—is ""no."" The XGBoost model's estimated probability for this outcome being ""yes"" is low at approximately 0.0689, suggesting that the likelihood of this diagnosis is very minimal. Furthermore, the patient has no recorded history of seizures or related diagnoses, and their significant history of arrhythmias and other complications related to their single-ventricle physiology are more dominant factors logically influencing their health status. Therefore, given the evidence at hand, it is reasonable to conclude that the patient likely does not have a diagnosis of seizures requiring medication.",1,0
BCH-PATMAR-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: BT shunt (reoperation was performed 7 days later)
 If other critical findings and/or intervention of first post-Fontan electrophysiologic study study, please specify: cardioverted x2 due to A fib
 Please provide any known details regarding the death: Sudden death, presumed EP arrest. Found sitting in chair at home.  So depends on how you code things. Real cause could be arrhythmia or hyperkalemia or PE or stroke or bleeding or other stuff.  Most likely arrhythmia. 
 Has the patient died? yes
 If yes to death, primary cause of death Malignant Arrhythmia/Arrhythmia arrest
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? yes
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? yes
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.04131616].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, it is predicted that the patient did not receive a heart transplant (no). The XGBoost model's predicted probability of the occluded outcome being 'yes' is extremely low at approximately 0.041, suggesting that, in most cases similar to this patient, a heart transplant was unlikely to have occurred. Additionally, the patient's significant history of arrhythmias, including a malignant arrhythmia leading to sudden death, along with complications such as intra-cardiac thrombus and ascites, typically complicate the clinical course, making successful transplant unlikely within that timeframe. The combination of these factors gives a strong indication that a heart transplant did not take place.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03295961].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict that the missing clinical outcome, ""Does the patient have a history of ascites (> trace)?"" is **no**. The patient does not show any history of significant complications typically associated with ascites, such as protein-losing enteropathy, liver dysfunction, or significant pleural effusion. Additionally, the XGBoost model suggests a low probability (3.30%) of the occluded outcome occurring, which aligns with the clinical features that reveal stability in the patient's post-surgical condition. Thus, the absence of these complications in conjunction with the model prediction supports the conclusion that the patient likely does not have a history of ascites.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.07443175].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, the predicted missing clinical outcome regarding whether the patient has a diagnosis of seizures requiring antiepileptic medications is **no**. The patient's history does not indicate any previous episodes of seizures or the use of antiepileptic medications, which is a significant factor in this prediction. Furthermore, the predicted probability of the occluded outcome being 'yes' is quite low (7.44%), suggesting that the likelihood of the patient having seizures is minimal. The absence of neurological complications such as stroke and the fact that the patient is hemodynamically stable after tachyarrhythmias further supports this conclusion.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00093131].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information and the XGBoost model's predicted probability of the occluded outcome being 'yes' as 0.00093131, it is highly likely that the patient did not receive a heart transplant. The patient's MRI report indicates a history of intracardiac thrombus and atrial tachyarrhythmias, both of which can complicate the decision for transplantation due to increased risks associated with surgical intervention and post-operative complications. Additionally, the absence of any indication of severe decompensation or other common transplant indications in the clinical status further supports the prediction that the patient did not undergo a heart transplant. Given the high accuracy of the model, I would conclude that the predicted outcome is 'no' for receiving a heart transplant.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03895076].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the model's predicted probability of the occluded outcome being 'yes' (0.03895), there is a very low likelihood that the patient has died. Additionally, the patient's comprehensive MRI report and history suggest stability, evidenced by no documented episodes of sustained ventricular tachyarrhythmias, stroke, or significant heart transplant history, which are typically correlated with poor outcomes. Moreover, the patient has a history of atrial tachyarrhythmias but seems to be managed without persistent life-threatening complications. Given this data and the strong accuracy of the model, it is reasonable to conclude that the patient has not died.",1,0
BCH-ROCAID-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify: possible coil-related thrombus in RSCA duringcath
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: Wide-complex tachycardia for 2-3 min unresponsive to adenosine and therefore cardioverted once with 50J with revision to sinus rhythm.An atrial stimulation study at the end of the case demonstrated a brisk AV node with appropriate conduction to rates of 230bpm. Etiology of tachycardia likely atrial with aberrant conduction. Hemodynamically stable following initial episode.
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00080105].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, the missing clinical outcome regarding the patient's history of pacemaker placement is predicted to be **no**. The patient does not have documented sinus node dysfunction or sustained tachyarrhythmias, which typically warrant a pacemaker. Moreover, the patient's underlying condition and surgical history, alongside the current medications and interventions, suggest a stable cardiac rhythm management without the need for a pacemaker. The low predicted probability (0.00080105) from the XGBoost model for the occluded outcome further supports this prediction.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00752685].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Given the provided data, the predicted probability of the occluded outcome (i.e., ""Has the patient died?"") is 0.00752685. This probability is very low, suggesting that the model highly favors the outcome of ""no"". Additionally, the patient has no significant complications noted in their medical history—such as cardiac arrest, major thrombus, or significant arrhythmias—which are often associated with higher mortality risk. Given the model's high accuracy of 0.96 and low predicted value for death, it is reasonable to conclude that the predicted outcome is ""no"" (the patient has not died).",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01098996].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data and the XGBoost model prediction probability of 0.01098996 for the outcome of having a history of ascites, it is reasonable to conclude that the patient likely does not have a history of ascites. This low probability indicates that the model finds minimal risk factors or signs in the patient's clinical profile, such as the absence of conditions frequently associated with ascites, like renal dysfunction, protein-losing enteropathy, or extensive pleural effusions, which are not documented in the history. Moreover, the patient's management does not include diuretics or other interventions typically aimed at treating fluid retention, supporting the prediction that the patient is less likely to have developed ascites. Therefore, I would predict the occluded outcome as ""no.""",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0008895].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the XGBoost model's predicted probability of the occluded outcome being 'yes' (0.0008895), there is a very low likelihood that the patient received a heart transplant. This aligns with the patient's current status and history. The absence of significant complications or critical cardiac issues (including arrhythmias, thrombus history, or the need for intensive interventions such as ECMO) suggests that the patient's single-ventricle condition has been managed without necessitating transplantation. Additionally, given the high accuracy (0.98) of the model and its strong performance metrics, it supports a prediction of 'no' regarding the patient receiving a heart transplant.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00071394].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, the predicted outcome for the patient regarding a history of pacemaker placement is ""no."" The XGBoost model predicts a very low probability (0.00071394) that the occluded outcome occurred, suggesting it is highly unlikely that the patient has a history of pacemaker placement. Additionally, the patient's MRI report and surgical history indicate no signs of significant cardiac dysfunction, arrhythmias, or other complications that would typically necessitate pacemaker placement. The absence of documented arrhythmias, cardiac events, or the need for antiarrhythmic interventions further supports that it is unlikely this patient underwent such a procedure.",1,0
BCH-RUTNEL-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01765855].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided information, it is reasonable to predict that the main patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The patient has no documented history of stroke, transient ischemic attacks, or any other neurological issues, which substantially reduces the likelihood of seizure activity. Additionally, the XGBoost model's predicted probability of the occluded outcome being 'yes' is only 1.77%, indicating a very low likelihood of the occurrence of seizures that would require medication. Given these factors, it aligns with the overall clinical picture that seizures are unlikely in this patient.",1,0
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.92140007].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? yes\n Did the patient receive a heart transplant? yes\n'],"Based on the high predicted probability of the occluded outcome being 'yes' (0.921) from the XGBoost model and the clinical history presented, it is highly likely that the patient did receive a heart transplant. The presence of protein-losing enteropathy, pleural effusions, and ascites suggests significant complications following the Fontan procedure, which can often lead to a patient's candidacy for transplant due to deteriorating health. Additionally, the history of atrial tachyarrhythmias and the requirement for emergency cardioversion further indicate a progression of cardiac issues that could necessitate transplantation. Thus, the evidence from both the clinical features and the predictive model strongly supports the conclusion that the patient did, in fact, receive a heart transplant.",1,1
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.0012969].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data and the prediction from the XGBoost model, it is highly likely that the patient does not have a history of pacemaker placement (predicted outcome: no). The patient's MRI report and surgical history indicate significant arrhythmogenic events, including a narrow complex SVT and a history of atrial tachyarrhythmias, but there is no record of pacemaker placement or essential descriptions that would imply reliance on pacing for management of these arrhythmias. Additionally, the model's estimated probability for the occluded outcome is extremely low at 0.0012969, indicating a strong likelihood that the patient has not undergone pacemaker placement in this context. Therefore, it is reasonable to conclude that the missing clinical outcome is 'no.'",1,0
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.8911593].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data, the predicted outcome for the question ""Has the patient died?"" is **yes**. The XGBoost model indicates a high predicted probability of 0.8911593 for the occluded outcome, suggesting that there is a significant likelihood that the patient has died. This aligns with the patient's complex medical history, which includes a prior heart transplant, multiple significant complications such as protein-losing enteropathy, chylous pleural effusions, atrial tachyarrhythmias, and a history of emergent cardioversion, all of which increase the risk for morbidity and mortality post-Fontan surgery. Given the patient's deteriorating conditions and the model's robust predictive accuracy of 0.96, it is reasonable to conclude that the patient likely did not survive.",0,0
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.63075835].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? yes\n'],"Based on the provided information, I predict that the patient has a history of ascites (> trace) and the answer is 'yes'. The patient's MRI report and surgical history indicate significant cardiopulmonary challenges after Fontan surgery, including protein-losing enteropathy and multiple persistent pleural effusions. These conditions are often associated with elevated venous pressures and fluid retention due to heart failure, which are likely contributing factors to the development of ascites. The XGBoost model’s estimated probability of the occluded outcome being 'yes' (0.63075835) further supports this prediction, indicating a relatively high likelihood that this patient experiences ascites as a clinical complication.",1,1
BCH-SILFIN-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: EP was called urgently to the cath lab after a long sheath was placed across the RVOT and SANO caused heart block.  Afterwards the patient went into a narrow complex SVT which did not respond to adenosine or DCCV
 Has the patient died? no
 Prior listing for a heart transplant? yes
 Did the patient receive a heart transplant? yes
  diagnosis of protein-losing enteropathy? yes
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? yes
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? yes
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.05658219].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I predict that the main patient does **not** have a diagnosis of seizures requiring antiepileptic medications (no). The XGBoost model yields a very low predicted probability of the occluded outcome being 'yes' at 0.05658219, suggesting a high likelihood that this outcome did not occur. Furthermore, the patient's medical history does not indicate any episodes consistent with seizures, such as alterations in consciousness or neurologic deficits, which strengthens the assessment that seizures requiring treatment are unlikely. Additionally, the absence of other relevant complications, such as a history of stroke or significant neurovascular issues, further supports this prediction.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00177462].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided data, I predict that the missing clinical outcome is ""no"" for the history of pacemaker placement. The main patient has a complex medical history, including a first intracardiac thrombus and anticoagulation management, yet there are no indications of arrhythmias or sustained tachyarrhythmias, conditions often leading to pacemaker placement. Additionally, the XGBoost model's predicted probability of 0.00177462, suggesting a very low likelihood of a pacemaker requirement, reinforces this prediction. Thus, given the absence of related complications or rhythm disorders in the patient's history, it is reasonable to conclude they do not have a history of pacemaker placement.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00865501].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided information, it is predicted that the patient did not receive a heart transplant ('no'). The primary reasons for this conclusion include the patient's current clinical status, which does not indicate severe complications typically requiring transplantation, such as significant renal dysfunction, pulmonary issues, or severe arrhythmias. Additionally, the XGBoost model's predicted probability of 0.00865501 strongly suggests that the likelihood of the patient needing a heart transplant is very low, supported by the impressive performance metrics of the model. Therefore, the patient's MRI and surgical history, alongside the statistical prediction, point away from the necessity of a heart transplant at this time.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.02600487].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, the predicted clinical outcome for the main patient regarding the history of ascites (> trace) is ""no."" The patient shows no signs of fluid accumulation-related issues, such as pleural effusions or renal dysfunction, which are often associated with ascites. The patient's excellent NYHA class and absence of significant cardiovascular complications lend further support to the notion that the patient is managing well post-Fontan surgery, reducing the likelihood of conditions like ascites. Additionally, the XGBoost model's estimated probability of the occluded outcome being 'yes' is quite low (0.02600487), indicating a strong expectation that the patient does not have a history of ascites.",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01556012].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the information provided regarding the main patient, the predicted probability for the occluded outcome (having a diagnosis of seizures requiring antiepileptic medications) is 0.01556012, which is very low and approaches zero. Additionally, the patient has no reported history of significant neurological issues such as stroke, transient ischemic attack, or intracardiac thrombus complications that might predispose them to seizures. Given the XGBoost model's high performance (accuracy of 0.94 and low predicted probability for seizures) and the absence of risk factors for seizures in the patient's clinical history, it is reasonable to conclude that the patient does not have a diagnosis of seizures requiring antiepileptic medications. Thus, the prediction is ""no.""",1,0
BCH-TARJOS-1," Pt Status Event Update 
 If other location of first intracardiac thrombus, please specify:  thrombosed LUPV stent
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? yes
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): yes
 Diuretic: yes
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.07301246].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the patient's profile and the XGBoost model prediction, I would predict that the missing clinical outcome, ""Has the patient died?"" is likely **no**. The patient's history reveals no significant acute events, such as major strokes or cardiac arrests, which are often associated with increased mortality risk. Additionally, the patient has not displayed any signs of severe complications, such as protein-losing enteropathy or significant renal dysfunction, which can complicate the health status in single-ventricle patients post-Fontan. The model's predicted probability of 0.07301246 suggests a low likelihood of mortality, aligning with the absence of critical adverse medical history in this case.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00116448].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided data and the XGBoost model prediction, it is highly likely that the main patient did not receive a heart transplant (no). The model estimates a very low probability (0.00116448) for the occluded outcome of receiving a heart transplant, indicating that the model strongly predicts this event did not occur. Additionally, the patient's MRI report and surgical history show no indications of significant complications or deterioration, such as heart failure symptoms or other conditions that might typically prompt a transplant. Given the high performance metrics of the XGBoost model, we can reasonably trust that the patient has not undergone heart transplantation.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00193613].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the available data and the predicted probability from the XGBoost model, it is highly likely that the occluded outcome—whether the patient has died—is 'no'. The patient has a comprehensive lack of serious complications or diagnoses typically associated with high mortality risk, such as strokes, cardiac arrests, or significant thrombus history. Additionally, the model’s predicted probability of death being only 0.00193613 further supports this, indicating an extremely low likelihood of the occluded outcome occurring. Given these findings, it appears that the patient is likely still alive.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01077081].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data, I predict that the patient does not have a diagnosis of seizures requiring antiepileptic medications (no). The XGBoost model indicates a very low predicted probability of 0.0108 for the occluded outcome being ""yes,"" suggesting that it is highly unlikely for this patient to have seizures that would necessitate antiepileptic treatment. Additionally, the patient's MRI report and surgical history indicate an absence of significant neurological events, such as stroke or transient ischemic attack, which are often associated with seizure development. Thus, this lack of history combined with the model's robust prediction supports the conclusion that the patient is unlikely to require such medication.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00066778].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, I predict that the patient does **not** have a history of pacemaker placement (no). The XGBoost model's predicted probability for the occluded outcome being ""yes"" is extremely low (0.00066778), indicating a negligible likelihood that the patient has experienced any complications typically associated with pacemaker placement, such as arrhythmias or related procedures. Additionally, the patient's clinical history shows no indications of significant arrhythmic complications; they do not exhibit any signs of atrial or ventricular tachyarrhythmias or require electrical interventions. This aligns with the absence of any documented issues that would necessitate pacemaker placement.",1,0
BCH-TOMCHR-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers yes
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01096194].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the XGBoost model's predicted probability of the occluded outcome being 'yes' at just 0.01096194, it strongly suggests that the patient does not have a history of ascites. Additionally, the patient's MRI report and surgical history show no indications of complications typically associated with ascites, such as elevated liver fibrosis or fluid accumulation issues post-Fontan surgery, as indicated by the absence of pleural effusions or hepatocellular carcinoma. Therefore, it is reasonable to conclude that the predicted clinical outcome for this patient is ""no,"" indicating that they do not have a history of ascites greater than trace.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.04286864].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the available information, the predicted outcome for ""Does the patient have a diagnosis of seizures requiring antiepileptic medications?"" is **no**. The XGBoost model predicts a probability of 0.04286864 for the occurrence of this outcome, which is significantly low and suggests that seizures are unlikely to be present in this patient. Moreover, the patient's MRI report and surgical history do not indicate any relevant neurological complications or prior diagnoses linked to seizure activity. Given that the patient has not had any documented history indicative of seizures or neurological events, and considering the model's high accuracy and reliable performance metrics, it further supports the conclusion that the patient does not have this diagnosis.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00150152].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? no\n Reason for pacemaker placement: Other\n'],"Based on the provided information, I predict that the missing clinical outcome—whether the patient has a history of pacemaker placement—is ""no."" The patient's MRI report and surgical history show no significant cardiac issues such as atrial tachyarrhythmias or sustained ventricular arrhythmias, which are common indications for pacemaker placement. Additionally, the XGBoost model's predicted probability of the occluded outcome being 'yes' is extremely low (0.0015), suggesting that there is a very low likelihood of such an intervention being necessary for this patient. Therefore, the absence of related complications and the extremely low risk factor lead to the conclusion that the patient does not have a history of pacemaker placement.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00720092].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, the predicted clinical outcome for the main patient is **no** for having a history of ascites (> trace). The patient does not report any complications typically associated with Fontan physiology, such as protein-losing enteropathy, pleural effusions, or hepatic dysfunction, which are often associated with the development of ascites. Additionally, the XGBoost model predicts a very low probability (0.0072) of the occluded outcome being 'yes', indicating that ascites is unlikely for this patient, corroborated by the patient's stable clinical features and lack of significant adverse outcomes thus far.",1,0
BCH-TRATRI-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00189202].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the information provided, it is reasonable to predict that the patient did not receive a heart transplant (no). The XGBoost model predicts an extremely low probability (0.00189) of the occluded outcome, indicating a strong likelihood that the patient has not undergone transplantation. Additionally, the patient's lack of major complications or significant cardiac dysfunction (evidenced by their current NYHA class status and absence of previously listed severe conditions) suggests that their heart function remains stable enough post-Fontan surgery to not necessitate transplantation. Therefore, combining the model's prediction with the patient's clinical status supports the conclusion that they likely did not receive a heart transplant.",1,0
BCH-TRATRI-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? no
  history of pacemaker placement? no
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00420783].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information, the predicted outcome for the question ""Has the patient died?"" is ""no."" The XGBoost model estimates a low probability of 0.0042 for the occluded outcome, suggesting a strong confidence that the patient remains alive. Additionally, the patient's comprehensive medical history shows no significant complications typically associated with increased mortality risk, such as substance use, major thromboembolic events, or significant post-operative complications. Given the model's high accuracy of 0.96 and the absence of severe adverse findings in the MRI report and surgical history, it is reasonable to conclude that this patient has not died.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.9956909].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the evidence provided, the missing clinical outcome, ""Does the patient have a history of pacemaker placement?"" would likely be ""yes."" The patient's surgical history includes significant arrhythmogenic events and specifically notes a history of sinus node dysfunction and atrial tachyarrhythmias. Given the high probability predicted by the XGBoost model (0.9956909) for an outcome likely associated with the need for cardiac rhythm management tools, it is reasonable to conclude that a pacemaker might have been placed to address these arrhythmias effectively. Furthermore, the patient's requirement for anticoagulation, pulmonary vasodilation, and his complex history reinforces the likelihood of device placement to manage significant cardiac conduction issues.",1,1
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01524258].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided data and the predicted probability from the XGBoost model, it is reasonable to predict that the occluded outcome, ""Has the patient died?"" is ""no."" The patient's medical history shows no major complications such as cardiac arrest, stroke, or significant thrombus formation, and there have been no reports of critical health events leading up to the present. Additionally, the model's predicted probability of death being ""yes"" is only 0.015, which indicates a very low likelihood of death in this cohort. Given the high performance metrics of the XGBoost model and the absence of critical events in the patient's history, it strongly suggests that the patient is alive.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.01184468].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided information, I predict that the patient does **not** have a history of ascites (> trace). The XGBoost model output indicates a very low predicted probability (0.0118) for the occurrence of the occluded outcome, suggesting that this patient is unlikely to have a significant history of ascites. Additionally, the patient's MRI report and surgical history show no diagnoses related to fluid accumulation or liver dysfunction, which further supports this prediction. Overall, the absence of prior or current complications related to liver or fluid management in the patient’s history aligns with the model's prediction of “no"" for ascites.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00091276].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data and the XGBoost model prediction of 0.00091276, it is reasonable to conclude that the patient likely did not receive a heart transplant (prediction: **no**). The patient's history of atrial tachyarrhythmias, syncope from wide complex tachycardia, and a requirement for a pacemaker indicate significant cardiac complications, yet the absence of other serious complications like protein-losing enteropathy, major thrombus, or renal dysfunction suggests stability despite ongoing cardiac management. Moreover, the very low probability predicted by the model implies that, even though the patient has a complex clinical history, the likelihood of needing a transplant is minimal in this case.",1,0
BCH-VAZAGU-1," Pt Status Event Update 
 Details of first emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest: soccer ball impact to chest with immediate syncope. EMS found him in a wide complex tachycardia~ 240 bpm which was terminated with cardioversion
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? no
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? yes
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? yes
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? yes
  history of post-Fontan electrophysiologic study? yes
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: no
 Beta blocker: no
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: yes
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.03238112].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? no\n'],"Based on the provided data for the main patient, the prediction for the missing clinical outcome—whether the patient has a diagnosis of seizures requiring antiepileptic medications—is ""no"". This conclusion is strongly supported by the absence of any reported history of seizures or neurological abnormalities in the patient's medical history. Furthermore, the XGBoost model's predicted probability of the occluded outcome being 'yes' is quite low at 0.032, suggesting a very low likelihood of seizures occurring in this patient population. Given the patient’s other cardiac and procedural complications, the focus seems to lean more toward their cardiac status rather than neurological issues.",1,0
BCH-WEIALE-1," Pt Status Event Update 
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.3319198].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.96
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.87

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.97      1.00      0.98       679
         1.0       0.73      0.27      0.39        30

    accuracy                           0.96       709
   macro avg       0.85      0.63      0.69       709
weighted avg       0.96      0.96      0.96       709


",Has the patient died?,[' Has the patient died? no\n'],"Based on the provided information and the model's predicted probability of 0.3319198 for the occluded outcome (death), it is reasonable to suggest that the patient has not died (predicted outcome: no). The patient's medical history shows no significant complications such as thrombus formation, significant arrhythmias, or severe organ dysfunction, which often correlate with higher mortality rates in single-ventricle patients post-Fontan. Additionally, the high model accuracy (96%) and relatively good sensitivity suggest that the model's predictions are reliable, particularly given that many unfavorable outcomes are not indicated in this patient’s clinical profile. Thus, despite the presence of some risk factors like sinus node dysfunction and the need for a pacemaker, the overall clinical picture does not strongly support a predicted outcome of death.",1,0
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.9933822].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 1.00
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 1.00

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       1.00      1.00      1.00       665
         1.0       1.00      0.98      0.99        46

    accuracy                           1.00       711
   macro avg       1.00      0.99      0.99       711
weighted avg       1.00      1.00      1.00       711


",Does the patient have a history of pacemaker placement?,['  history of pacemaker placement? yes\n Reason for pacemaker placement: Other\n'],"Based on the provided information, the prediction for the missing clinical outcome, ""Does the patient have a history of pacemaker placement?"" is **yes**. The patient’s history indicates sinus node dysfunction, which commonly justifies the placement of a pacemaker to manage bradyarrhythmias associated with this condition. Furthermore, given the XGBoost model's high predicted probability of 0.9933822 for the occluded outcome, it reinforces that the patient likely has a previous need for pacing support, aligning with the patterns observed in similar cohorts. Therefore, the evidence strongly suggests that this patient has a history of pacemaker placement.",1,1
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.17247081].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.94
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.86

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      1.00      0.97       665
         1.0       0.60      0.07      0.12        46

    accuracy                           0.94       711
   macro avg       0.77      0.53      0.54       711
weighted avg       0.92      0.94      0.91       711


",Does the patient have a diagnosis of seizures requiring antiepileptic medications?,['  diagnosis of seizures requiring antiepileptic medications? yes\n'],"Based on the provided data and the prediction from the XGBoost model, it is likely that the missing clinical outcome regarding the diagnosis of seizures requiring antiepileptic medications is ""no."" The patient's clinical history reveals no significant neurological complications, such as strokes or transient ischemic attacks, which often precede seizure disorders. Additionally, the patient's low predicted probability of 0.172 indicates that the model assesses a low likelihood of seizures being present, aligning with the absence of any indication of a seizure diagnosis in the history. Furthermore, the patient is on medications such as beta blockers and diuretics, which are common in managing heart conditions but do not indicate seizures, reinforcing the prediction of ""no"" for this outcome.",0,1
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? yes
 Prior listing for a heart transplant? no
 Did the patient receive a heart transplant? no
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.32011402].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.93
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.88

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.94      0.99      0.96       653
         1.0       0.67      0.25      0.36        57

    accuracy                           0.93       710
   macro avg       0.80      0.62      0.66       710
weighted avg       0.92      0.93      0.91       710


",Does the patient have a history of ascites (> trace)?,['  history of ascites (> trace)? no\n'],"Based on the provided data, I would predict that the patient does **not** have a history of ascites (> trace). The MRI report and surgical history indicate significant management of potential complications, as the patient has no diagnosis of protein-losing enteropathy or major vascular thrombus, both of which can often lead to fluid accumulation. Additionally, despite the presence of non-chylous pleural effusions >30 days after surgery, there are no other suggestive signs of volume overload or systemic congestion, which might correlate with ascites. The XGBoost model's predicted probability of the occluded outcome suggests a higher chance that the patient sustains no history of ascites (0.32) with the high performance of the model reinforcing this prediction. Thus, the most logical conclusion is that the patient's risk factors do not indicate a history of significant ascites.",1,0
BCH-WEIALE-1," Pt Status Event Update 
 Has the patient died? no
  diagnosis of seizures requiring antiepileptic medications? yes
  diagnosis of protein-losing enteropathy? no
  diagnosis of plastic bronchitis? no
  diagnosis of intracardiac or major vascular thrombus? no
  history of stroke (peri-op)? no
  history of stroke (non peri-op)? no
  history of transient ischemic attack (non peri-op)? no
  history of cardiac arrest (peri-op)? no
  history of cardiac arrest (non peri-op)? no
  history of pleural effusion, chylous greater than 30 days after surgery? no
  history of pleural effusions, non-chylous, greater than 30 days after surgery? yes
  history of a positive fibrosure or significantly elevated liver fibrosis test? no
  history of ascites (> trace)? no
  history of hepatocellular carcinoma? no
  history of renal dysfunction defined as a GFR < 60 or Dialysis; excluding peri-operative renal dysfunction? no
  history of hemoptysis? no
  history of Extra Corporeal Membrane Oxygenation (ECMO)? no
  history of atrial tachyarrhythmias, atrial fibrillation, atrial flutter, or atrial tachycardia? no
  history of non-sustained ventricular tachyarrhythmias? no
  history of sustained ventricular tachyarrhythmias, ventricular tachycardia, ventricular fibrillation, lasting more than 30 seconds? no
  history of elective cardioversion? no
  history of emergent cardioversion, defibrillation, or arrhythmogenic cardiac arrest? no
  history of post-Fontan electrophysiologic study? no
  history of sinus node dysfunction? yes
  history of pacemaker placement? yes
  history of defibrillator use? no
 Current NYHA class: yes
 Anticoagulant / anti-platelet: yes
 Angiotensin Converting Enzyme Inhibitor (ACE-I) / Angiotensin Receptor Blocker (ARB): no
 Diuretic: yes
 Beta blocker: yes
 Antidepressants, anti-anxiety, stimulants, antipsychotics, and/or mood stabilizers no
 Pulmonary Vasodilator: no
 Location of first intracardiac thrombus: Other {hx_thrombus_loc_other}
 Critical findings and/or intervention of first post-Fontan electrophysiologic study: Other
 Reason for pacemaker placement: Other
 Reason for defibrillator placement: Other
 Type(s) of anticoagulant / antiplatelet: Other {meds_anticoag_other}
","Additionally, an XGBoost model estimates the predicted probability of the occluded outcome being 'yes' to be: [0.00805685].
This prediction is based on a model trained and validated on the set of clinical features you were given. The dataset includes a similar cohort of patients, but not the patient in question.

The XGBoost model performs very well so take it's prediction with a lot of weight. Specifically, it achieved the following performance metrics on the validation set (excluding the test patient):
 - Accuracy: 0.98
 - Area Under the Receiver Operating Characteristic (AUC-ROC) Curve: 0.93

In this model, a predicted value of 0 indicates the model predicts the occluded outcome did not occur for a given patient, while a predicted value of 1 indicates the model predicts it did occur.

Classification Report:
              precision    recall  f1-score   support

         0.0       0.99      1.00      0.99       695
         1.0       0.78      0.44      0.56        16

    accuracy                           0.98       711
   macro avg       0.88      0.72      0.78       711
weighted avg       0.98      0.98      0.98       711


",Did the patient receive or was listed for a heart transplant?,[' Prior listing for a heart transplant? no\n Did the patient receive a heart transplant? no\n'],"Based on the provided patient data and the low predicted probability (0.0081) of the occluded outcome being 'yes', it is highly likely that the patient did not receive a heart transplant. The absence of critical complications such as stroke, significant arrhythmias, or thrombus, alongside the utilization of a pacemaker and anticoagulation indicates some cardiac stability, which is often a prerequisite for avoiding transplantation in single-ventricle patients. Furthermore, the patient’s current NYHA class and management with multiple medications suggest adequate management of their condition without the need for transplant, leading us to conclude that the missing outcome is 'no' for having received a heart transplant.",1,0
